Shenouda Maged
Insider CIK 1658369 · PRGB Director · RLMD Chief Financial Officer, Director · AZRX CHIEF FINANCIAL OFFICER, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2026-09-10 | 2026-09-11 | 79,800 | $4.25 | $339.1K | 1,000,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2026-09-10 | 2026-09-11 | 79,800 | $4.25 | $339.1K | 1,000,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2026-09-09 | 2026-09-11 | 120,200 | $4.20 | $504.8K | 920,200 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2026-09-09 | 2026-09-11 | 120,200 | $4.20 | $504.8K | 920,200 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2025-12-15 | 2025-12-16 | 11,665 | $4.12 | $48.1K | 800,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2025-12-12 | 2025-12-16 | 828,000 | — | $0 | 828,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2025-11-05 | 2025-11-06 | 500,000 | $2.20 | $1.10M | 788,335 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2025-06-26 | 2025-06-30 | 600,000 | — | $0 | 600,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2025-05-20 | 2025-05-20 | 60,000 | $0.52 | $31.2K | 288,335 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2025-05-19 | 2025-05-20 | 90,000 | $0.49 | $44.1K | 228,335 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2025-05-16 | 2025-05-20 | 50,000 | $0.44 | $22.0K | 138,335 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2024-09-11 | 2024-09-11 | 24,120 | $2.95 | $71.2K | 88,335 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2024-09-10 | 2024-09-11 | 21,118 | $2.73 | $57.7K | 64,215 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2024-09-09 | 2024-09-11 | 8,194 | $2.55 | $20.9K | 43,097 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | J Other deriv | 2024-05-24 | 2024-05-29 | 54,624 | — | $0 | 82,090 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2024-05-24 | 2024-05-29 | 54,624 | — | $0 | 136,714 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2024-01-31 | 2024-01-31 | 6,875 | $4.06 | $27.9K | 34,903 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2024-01-30 | 2024-01-31 | 15,000 | $3.89 | $58.4K | 28,028 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2024-01-29 | 2024-01-31 | 10,800 | $3.65 | $39.4K | 13,028 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2023-12-15 | 2023-12-19 | 82,090 | — | $0 | 82,090 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2023-05-25 | 2023-05-30 | 317,643 | — | $0 | 512,560 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2022-12-16 | 2022-12-20 | 194,917 | — | $0 | 194,917 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | J Other deriv | 2022-12-16 | 2022-12-20 | 200,000 | — | $0 | 0 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2022-05-25 | 2022-05-26 | 295,211 | — | $0 | 522,729 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2022-05-25 | 2022-05-26 | 200,000 | — | $0 | 200,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2021-12-17 | 2021-12-21 | 227,518 | — | $0 | 227,518 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-03-10 | 2021-03-10 | 2,373 | $35.11 | $83.3K | 2,228 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-03-09 | 2021-03-10 | 5,727 | $35.42 | $202.9K | 6,401 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-03-09 | 2021-03-10 | 1,800 | $36.02 | $64.8K | 4,601 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-03-08 | 2021-03-10 | 10,000 | — | $0 | 70,350 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-03-08 | 2021-03-10 | 100 | $35.00 | $3.5K | 12,128 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-03-08 | 2021-03-10 | 10,000 | $3.24 | $32.4K | 12,228 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-02-24 | 2021-02-26 | 3,000 | — | $0 | 80,250 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-24 | 2021-02-26 | 1,400 | $34.67 | $48.5K | 2,228 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-24 | 2021-02-26 | 1,600 | $33.74 | $54.0K | 3,628 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-02-24 | 2021-02-26 | 3,000 | $3.24 | $9.7K | 5,228 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-02-11 | 2021-02-16 | 1,428 | — | $0 | 83,250 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-02-11 | 2021-02-16 | 1,428 | $3.24 | $4.6K | 3,656 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-11 | 2021-02-16 | 1,428 | $35.39 | $50.5K | 2,228 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-10 | 2021-02-10 | 2,410 | $35.20 | $84.8K | 2,228 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-09 | 2021-02-10 | 5,359 | $35.24 | $188.9K | 4,638 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-02-08 | 2021-02-10 | 11,372 | — | $0 | 84,678 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-02-08 | 2021-02-10 | 11,372 | $3.24 | $36.8K | 13,600 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-08 | 2021-02-10 | 3,603 | $35.04 | $126.2K | 9,997 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-03 | 2021-02-04 | 100 | $35.00 | $3.5K | 2,228 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-02-02 | 2021-02-04 | 3,200 | — | $0 | 96,050 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-02-02 | 2021-02-04 | 3,200 | $3.24 | $10.4K | 5,428 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-02-02 | 2021-02-04 | 3,100 | $35.04 | $108.6K | 2,328 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-01-27 | 2021-01-29 | 3,000 | — | $0 | 99,250 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-01-27 | 2021-01-29 | 1,200 | $32.43 | $38.9K | 2,228 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-01-27 | 2021-01-29 | 3,000 | $3.24 | $9.7K | 5,228 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-01-27 | 2021-01-29 | 1,800 | $31.59 | $56.9K | 3,428 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-01-26 | 2021-01-26 | 607 | $35.16 | $21.3K | 2,228 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-01-25 | 2021-01-26 | 1,280 | $35.27 | $45.1K | 2,835 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise deriv | 2021-01-22 | 2021-01-26 | 4,000 | — | $0 | 102,250 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-01-22 | 2021-01-26 | 409 | $36.15 | $14.8K | 4,115 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-01-22 | 2021-01-26 | 4,000 | $324.00 | $1.30M | 6,228 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | S Sale | 2021-01-22 | 2021-01-26 | 1,704 | $35.41 | $60.3K | 4,524 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | M Exercise | 2021-01-22 | 2021-01-27 | 4,000 | $3.24 | $13.0K | 6,228 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2021-01-07 | 2021-01-11 | 127,500 | — | $0 | 127,500 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2021-01-07 | 2021-01-11 | 127,500 | — | $0 | 127,500 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2019-12-19 | 2019-12-23 | 120,000 | $43.47 | $5.22M | 120,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2019-10-21 | 2019-10-21 | 978 | $23.00 | $22.5K | 2,228 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2019-07-29 | 2019-07-30 | 500,000 | $2.20 | $1.10M | 500,000 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | P Buy | 2018-12-28 | 2019-01-02 | 20,000 | $1.31 | $26.2K | 62,500 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2018-12-20 | 2018-12-20 | 450,000 | $1.15 | $517.5K | 450,000 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award deriv | 2018-07-12 | 2018-07-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | A Award deriv | 2017-10-20 | 2017-10-23 | 425,000 | $0.81 | $344.3K | 425,000 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award | 2017-10-19 | 2017-10-23 | 22,500 | — | $0 | 42,500 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award deriv | 2017-09-25 | 2017-09-27 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AZRX AzurRx BioPharma, Inc. | A Award deriv | 2017-02-03 | 2017-02-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PRGB Protea Biosciences Group, | A Award deriv | 2015-12-18 | 2016-01-07 | 66,667 | — | $0 | 66,667 | SEC↗ |
| PRGB Protea Biosciences Group, | A Award | 2015-12-18 | 2016-01-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-15 | 2015-12-17 | 241 | $2.99 | $721 | 4,241 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-15 | 2015-12-17 | 2,000 | $2.98 | $6.0K | 4,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-15 | 2015-12-17 | 759 | $3.00 | $2.3K | 5,000 | SEC↗ |
| RLMD RELMADA THERAPEUTICS, INC. | P Buy | 2015-12-14 | 2015-12-16 | 2,000 | $2.89 | $5.8K | 2,000 | SEC↗ |